Elicio Therapeutics

ELTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$49.147 M

$1.87 -2.09%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$39.6M

Loss-making

Shares outstanding

26,281,882

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#353Dogwood TherapeuticsDWTX$51.3M
#354Filana TherapeuticsFLNA$49.8M
#355Elicio TherapeuticsELTX$49.1M
#356Mereo BioPharma GroupMREO$49.1M
#357ScynexisSCYX$48.4M

What if Elicio Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,150,373

Per share 615,173× higher

Bitcoin $1.74T

$66,268.28

Per share 35,438× higher

Nvidia $5.52T

$209,869.56

Per share 112,230× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Elicio Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.